Paces Ferry Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Paces Ferry Wealth Advisors's NVO Position: Q1 2026 in Review
Paces Ferry Wealth Advisors sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,040 shares — an estimated $206K sold.
Paces Ferry Wealth Advisors first reported a position in NVO in Q3 2020 and held it in 17 quarters. The position peaked at $476K in Q2 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Paces Ferry Wealth Advisors reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Paces Ferry Wealth Advisors sold 4,040 Novo Nordisk shares in Q1 2026, an estimated $206K.
- Paces Ferry Wealth Advisors first reported a position in Novo Nordisk in Q3 2020 and held it in 17 quarters.
- Paces Ferry Wealth Advisors's Novo Nordisk position peaked at $476K in Q2 2024.
- 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Paces Ferry Wealth Advisors's 13F filing for Q1 2026, filed 6 May 2026.